Enriching Women's Life Stories: Investment Executed in YStory Inc.
Mirai Door Co., Ltd. and Asuka Pharmaceutical Co., Ltd. announced that their joint venture fund, Asuka Innovation Fund, has invested in YStory Inc., a startup providing cutting-edge femtech solutions to improve health literacy and realize positive aging.
📋 Article Processing Timeline
- 📰 Published: April 29, 2026 at 00:00
- 🔍 Collected: April 28, 2026 at 15:31
- 🤖 AI Analyzed: April 28, 2026 at 15:47 (15 min after Collected)
## Press Release Information
Mirai Door Co., Ltd. (Headquarters: Minato-ku, Tokyo; Chairman and President: Daisuke Sawada; hereinafter "Mirai Door") is pleased to announce that the Asuka Innovation Investment Limited Partnership (hereinafter "Asuka Innovation Fund"), established jointly with Asuka Pharmaceutical Co., Ltd. (Headquarters: Minato-ku, Tokyo; President: Sohta Yamaguchi; hereinafter "Asuka Pharmaceutical"), has executed an investment in YStory Inc. (Headquarters: Shinagawa-ku, Tokyo; Representative Directors: Sherry Shi, Janet Yu; hereinafter "YStory"). YStory provides cutting-edge technology for improving health literacy and achieving positive aging.
### About the Investee Company
YStory is a startup providing cutting-edge technology in the femtech domain. YStory's flagship service, "JoyHer (patent pending)," is a smartphone application that supports the health of menopausal women. Based on a data-driven and evidence-based approach, it provides personalized self-care advice to each individual. It also offers a community space where women who have experienced menopausal symptoms can connect with each other. YStory aims to continue developing various services to contribute to health literacy and positive aging.
**Company Profile: YStory Inc.**
- **Trade Name:** YStory Inc.
- **Representative Directors:** Sherry Shi, Janet Yu
- **Headquarters:** 6-1-1-202 Nishi-Ooi, Shinagawa-ku, Tokyo
- **Established:** January 2023
- **URL:** https://ystoryhealth.com/
### About Asuka Innovation Fund
**1. Investment Purpose**
The fund invests with the aim of securing "strategic returns" through investments in startup companies where business synergies with Asuka Pharmaceutical and its group companies are expected.
**2. Investment Themes**
- Startups aimed at solving issues related to menstruation, infertility, and menopausal disorders.
- Startups researching new modalities and drug delivery in pharmaceutical research.
- Startups developing new digital health services and applications.
- Startups engaged in animal health and diagnostic businesses.
### About Mirai Door
Mirai Door works on "Regional Revitalization Funds" to support regional venture companies, "CVC Funds" to promote open innovation for business corporations, and "Theme-based Funds" that support industry activation in specific investment fields. In addition to providing capital, Mirai Door offers support such as business development, human resource development, and business consulting for long-term business continuity.
**Company Profile: Mirai Door Co., Ltd.**
- **Trade Name:** Mirai Door Co., Ltd. (A 100% subsidiary of AI Fusion Capital Group Inc., TSE Standard Securities Code: 254A)
- **Chairman and President:** Daisuke Sawada
- **Headquarters:** 1-9-9 Roppongi, Minato-ku, Tokyo
- **URL:** https://www.fvc.co.jp/
Mirai Door Co., Ltd. (Headquarters: Minato-ku, Tokyo; Chairman and President: Daisuke Sawada; hereinafter "Mirai Door") is pleased to announce that the Asuka Innovation Investment Limited Partnership (hereinafter "Asuka Innovation Fund"), established jointly with Asuka Pharmaceutical Co., Ltd. (Headquarters: Minato-ku, Tokyo; President: Sohta Yamaguchi; hereinafter "Asuka Pharmaceutical"), has executed an investment in YStory Inc. (Headquarters: Shinagawa-ku, Tokyo; Representative Directors: Sherry Shi, Janet Yu; hereinafter "YStory"). YStory provides cutting-edge technology for improving health literacy and achieving positive aging.
### About the Investee Company
YStory is a startup providing cutting-edge technology in the femtech domain. YStory's flagship service, "JoyHer (patent pending)," is a smartphone application that supports the health of menopausal women. Based on a data-driven and evidence-based approach, it provides personalized self-care advice to each individual. It also offers a community space where women who have experienced menopausal symptoms can connect with each other. YStory aims to continue developing various services to contribute to health literacy and positive aging.
**Company Profile: YStory Inc.**
- **Trade Name:** YStory Inc.
- **Representative Directors:** Sherry Shi, Janet Yu
- **Headquarters:** 6-1-1-202 Nishi-Ooi, Shinagawa-ku, Tokyo
- **Established:** January 2023
- **URL:** https://ystoryhealth.com/
### About Asuka Innovation Fund
**1. Investment Purpose**
The fund invests with the aim of securing "strategic returns" through investments in startup companies where business synergies with Asuka Pharmaceutical and its group companies are expected.
**2. Investment Themes**
- Startups aimed at solving issues related to menstruation, infertility, and menopausal disorders.
- Startups researching new modalities and drug delivery in pharmaceutical research.
- Startups developing new digital health services and applications.
- Startups engaged in animal health and diagnostic businesses.
### About Mirai Door
Mirai Door works on "Regional Revitalization Funds" to support regional venture companies, "CVC Funds" to promote open innovation for business corporations, and "Theme-based Funds" that support industry activation in specific investment fields. In addition to providing capital, Mirai Door offers support such as business development, human resource development, and business consulting for long-term business continuity.
**Company Profile: Mirai Door Co., Ltd.**
- **Trade Name:** Mirai Door Co., Ltd. (A 100% subsidiary of AI Fusion Capital Group Inc., TSE Standard Securities Code: 254A)
- **Chairman and President:** Daisuke Sawada
- **Headquarters:** 1-9-9 Roppongi, Minato-ku, Tokyo
- **URL:** https://www.fvc.co.jp/